SAMUEL ROBERTS: Open Payments
NPI 1285219477 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 21 payments from 9 companies in 2025. Trend: 2023 $119 · 2024 $493 · 2025 $781
Food & beverage: $682Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $462 |
| Janssen Biotech, Inc. | 2 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| GENZYME CORPORATION | 1 | $24 |
| Organon LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| QOL Medical, LLC | 1 | $15 |
Products named: SKYRIZI, RINVOQ, TREMFYA, MAVYRET, ENTYVIO, DUPIXENT, XIFAXAN, HADLIMA.
Industry payments across GA — which companies pay providers there.
